Volume : 9, Issue : 1, January - 2020

MICROALBUMINURIA - AN INCREASINGLY RECOGNIZED CARDIOVASCULAR RISK FACTOR

Dr. S. Aruna, Dr. J. Sowndharya, Dr. R. S. Monish Anand

Abstract :

Aim: The Aim of the study is to determine the prevalence of Microalbuminuria in newly diagnosed patients with Type 2 Diabetes Mellitus and to compare the effectiveness of Microalbuminuria with the fasting Lipid profile in detecting Cardiovascular risk in these patients in terms of Atherogenic Index. Material &Methods: The study group includes 100 patients with Type 2 Diabetes Mellitus. Patients with urinary tract infection, Macro albuminuria, Renal failure and Heart failure are excluded from the study. Fasting and post-prandial blood sugar, Fasting Lipid profile, Atherogenic Index, Creatinine and Urine Albumin are measured in all the patients. The patients were divided in to two groups: Group A without Microalbuminuria and Group B with Microalbuminuria. Results: BMI, FBS, PPBS, Total Cholesterol, TGL, Atherogenic Index, Creatinine and Urine Albumin are found to be higher in Group B compared to Group A patients and Serum HDL is found to be lower in Group B compared to Group A patients. Pearson correlation coefficient of Atherogenic Indices with Urine Albumin excretion of Group B patients shows that there is a significant positive correlation (r = 0.5981). Conclusion: Microalbuminuria can be used as an independent marker for early prediction of Cardiovascular complications and can be used as a screening procedure in all patients diagnosed with type 2 Diabetes mellitus.